---
title: "SOLLIS GARY — Ownership Dossier"
canonical: https://whiteintel.dev/entity/57e52e7e-bc40-55dd-87aa-ed4aa2f611f0
json: https://whiteintel.dev/api/public/dossier/57e52e7e-bc40-55dd-87aa-ed4aa2f611f0
identifier: sec:0001826324
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# SOLLIS GARY

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001826324`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/57e52e7e-bc40-55dd-87aa-ed4aa2f611f0  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/57e52e7e-bc40-55dd-87aa-ed4aa2f611f0  

## Ownership & control

### Holdings / subsidiaries

- **ESSA PHARMA INC.** (director) — https://whiteintel.dev/entity/a496bea7-7d30-5e59-8841-ba61e99e06cf

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **SOLLIS GARY**. Human view: https://whiteintel.dev/entity/57e52e7e-bc40-55dd-87aa-ed4aa2f611f0 · Structured JSON: https://whiteintel.dev/api/public/dossier/57e52e7e-bc40-55dd-87aa-ed4aa2f611f0._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._